You are viewing: US Sleep Apnea Devices Market analysis
Part of: Sleep Apnea Devices Market (Global)

The US Sleep Apnea Devices Market was valued at $2752.8 Million in 2025 and projected to reach to $4708.6 Million by 2030, representing a compound annual growth rate of 8.0%. The US sleep apnea devices market is positioned for sustained growth through 2030, driven by rising disease prevalence, improved diagnostic capabilities, and technological innovation in treatment options.

US Sleep Apnea Devices Market Trends and Insights

  • This robust expansion in the US reflects rising prevalence of obstructive sleep apnea, increased diagnostic awareness, and growing adoption of advanced therapeutic devices among American patients.
  • The US market benefits from strong healthcare infrastructure, favorable reimbursement policies, and significant investment in sleep medicine innovation. Driving growth in the US are demographic shifts toward an aging population, higher obesity rates, and improved screening protocols that identify previously undiagnosed cases.
  • The US sleep apnea devices market is also supported by technological advancements in continuous positive airway pressure (CPAP) machines, bilevel positive airway pressure (BiPAP) devices, and emerging alternatives.
  • Between 2025 and 2030, the US market will see intensified competition among established manufacturers and new entrants seeking to capture share in this high-growth segment..

Key Market Statistics

  • CAGR (2025-2030) 8.0% CAGR
  • Market Size, 2025 ~USD 2752.8 Million
  • Forecast, 2030 ~USD 4708.6 Million
  • Country US

US Sleep Apnea Devices Market Overview

Market Size & Growth :

The US sleep apnea devices market is valued at $2,752.8 million in 2025 and is projected to reach $4,708.6 million by 2030, growing at a CAGR of 8.0%, outpacing the global growth rate of 7.6%.

Rising OSA Prevalence :

Increasing prevalence of obstructive sleep apnea among American adults, driven by obesity rates and aging demographics, is fueling demand for diagnostic and therapeutic devices across the US healthcare system.

Diagnostic Awareness Expansion :

Enhanced awareness campaigns and improved screening protocols in the US are leading to earlier diagnosis of sleep apnea, expanding the addressable patient population and driving device adoption rates.

Advanced Technology Adoption :

US patients and healthcare providers are increasingly adopting next-generation devices including portable diagnostic tools, cloud-connected CPAP machines, and alternative therapeutic solutions for better compliance and outcomes.

US Sleep Apnea Devices Market Dynamics

  • Healthcare providers are increasingly investing in sleep medicine infrastructure, while insurance coverage expansion supports patient access to advanced devices.
  • The market will benefit from growing consumer awareness of sleep apnea's health impacts and the availability of more comfortable, user-friendly therapeutic solutions.
  • Competitive innovation and strategic partnerships among US-based and international manufacturers will further accelerate market expansion, with particular growth in home-based diagnostic and remote monitoring technologies..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Stryker Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The US sleep apnea devices market will expand from $2,752.8M (2025) to $4,708.6M (2030) at an 8.0% CAGR.
    • Rising obesity rates and aging demographics in the US are primary drivers of increased sleep apnea diagnosis and device adoption.
    • The US market is characterized by strong reimbursement coverage and advanced healthcare infrastructure supporting device accessibility.
    • Technological innovation in CPAP, BiPAP, and alternative therapies will intensify competition among US market participants through 2030.

    Sleep Apnea Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment ORAL APPLIANCES (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 7.6% from 2025 to 2030
    Largest Segment THERAPEUTIC DEVICES (Product)
    Market Size Base Year (Billions) ~USD 6.95 (2025)
    Revenue Forecast (Billions) ~USD 10.03 (2030)
    Segments Covered Product, Type

    US Sleep Apnea Devices Market Report Segmentation

    2 segment dimensions are covered across the global market.

    By Product

    • Diagnostic Devices
    • Therapeutic Devices

    By Type

    • Accessories
    • Actigraphy Systems
    • Ambulatory Psg Devices
    • Apap Devices
    • Bpap Devices
    • Chin Restraints
    • Clinical Psg Devices
    • Communication Accessories
    • Cpap Devices
    • Cushions
    • Daytime-Nighttime Appliances
    • Facial Interfaces
    • Full-Face Masks
    • Home Sleep Testing Devices
    • Humidifier Accessories
    • Mandibular Advancement Devices
    • Masks
    • Nasal Masks
    • Nasal Pillow Masks
    • Oral Appliances
    • Other Accessories
    • Other Therapeutic Devices
    • Oximeters
    • Pap Devices
    • Power Accessories
    • Psg Devices
    • Sleep Screening Devices
    • Tongue-Retaining Devices
    • Transportation Accessories

    Target Audience

    • Medical Device Manufacturers : US-based and international manufacturers need detailed market sizing, growth projections, and competitive insights to guide R&D investments, product launches, and market expansion strategies in the American sleep apnea device sector.
    • Healthcare Providers & Hospital Systems : US hospitals, sleep centers, and clinical networks require market intelligence to optimize device procurement strategies, evaluate emerging technologies, and plan sleep medicine service expansion to meet growing patient demand.
    • Investors & Private Equity Firms : Investment professionals evaluating opportunities in US healthcare need comprehensive market data, growth forecasts, and trend analysis to assess investment potential and identify acquisition targets in the sleep apnea device market.
    • Distributors & Medical Device Retailers : US medical device distributors and retailers need market forecasts and growth driver analysis to optimize inventory management, negotiate supplier contracts, and develop sales strategies aligned with market expansion.
    • Healthcare Consultants & Analysts : Consulting firms and research analysts serving healthcare clients require detailed US market data and insights to support client advisory work, competitive analysis, and strategic recommendations in sleep medicine.

    Key Companies in the US Sleep Apnea Devices Market

    CompanyHQOwnershipStrongest segments
    HENRY SCHEINUnited StatesPublic CompanyTherapeutic – Oral Appliances,Therapeutic – PAP Devices (CPAP, APAP, BPAP),Therapeutic – Masks and Consumables,
    ROSSMAX INTERNATIONAL LTDTaiwanPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    SANOFISpainPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    DANAHER CORPORATIONUnited StatesPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    RESMEDUnited StatesPublic CompanyTherapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks and Interfaces,Therapeutic – Oral Appliances,
    FISHER & PAYKEL HEALTHCARE LIMITEDNew ZealandPublic CompanyTherapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances,
    INSPIRE MEDICAL SYSTEMS, INC.United StatesPublic CompanyTherapeutic – Neurostimulation System (competes with PAP/Oral Appliances/Masks),Diagnostic-Linked Services (competes with PSG/Home Sleep Testing/Oximeter adjacencies),
    SOMNOMEDAustraliaPublic CompanyTherapeutic – Oral Appliances (SomnoDent portfolio, SomMorning Repositioner, SomnoBrux),Adjacencies – Cleaning and maintenance (SomTabs) and related accessories,Non-OSA dental protection (SomnoBrux-only use cases),
    COMPUMEDICS LIMITEDAustraliaPublic CompanyDiagnostic – PSG Systems (lab-based and ambulatory),Diagnostic – Home Sleep Testing & Wearables,Diagnostic – Oximetry and Ancillary Monitoring,
    BMCUnited StatesPrivate CompanyTherapeutic Devices (PAP, Oral Appliances, Masks),Diagnostic Devices (PSG, Home Sleep Testing, Oximeter),Healthcare IT / Workflow Enablement for Sleep Care,
    PROSOMNUS SLEEP TECHNOLOGIESUnited StatesPrivate CompanyTherapeutic – Oral Appliances,Therapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks,

    HENRY SCHEIN

    Henry Schein is a publicly traded United States company founded in 1932 with 25,000 employees.

    ROSSMAX INTERNATIONAL LTD

    Rossmax International Ltd is a publicly traded company based in Taiwan, founded in 1988.

    SANOFI

    Sanofi is a publicly traded pharmaceutical company based in Spain, founded in 1994 with 74,846 employees.

    DANAHER CORPORATION

    Danaher Corporation is a publicly traded United States company founded in 1969 with 59,000 employees.

    RESMED

    ResMed is a publicly traded United States company founded in 1989 with 10,600 employees.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a publicly traded Dutch company founded in 1891 with 64,317 employees.

    FISHER & PAYKEL HEALTHCARE LIMITED

    Fisher & Paykel Healthcare Limited is a publicly traded New Zealand company founded in 1934 with 7,396 employees.

    INSPIRE MEDICAL SYSTEMS, INC.

    Inspire Medical Systems, Inc. is a publicly traded United States company founded in 2007 with 1,333 employees.

    SOMNOMED

    SomnoMed is a publicly traded Australian company founded in 1987 with 300 employees.

    COMPUMEDICS LIMITED

    Compumedics Limited is a publicly traded Australian company founded in 1987 with 175 employees.

    BMC

    BMC is a United States-based private company founded in 1980 with 6,700 employees.

    PROSOMNUS SLEEP TECHNOLOGIES

    ProSomnus Sleep Technologies is a United States-based private company founded in 2016 with 136 employees.

    Reasons to Buy this Report

    • Market Size & Forecast Data : Access precise US market valuations ($2.75B in 2025, $4.71B in 2030) with detailed CAGR analysis to support investment decisions, business planning, and competitive positioning in the American sleep apnea device sector.
    • Growth Driver Insights : Understand key US-specific growth catalysts including rising OSA prevalence, diagnostic awareness expansion, and advanced technology adoption to identify market opportunities and develop targeted go-to-market strategies.
    • Competitive Landscape Intelligence : Gain insights into the US competitive environment, including market dynamics, innovation trends, and strategic positioning of manufacturers to benchmark performance and identify differentiation opportunities.
    • Regulatory & Reimbursement Context : Understand the US healthcare landscape, insurance coverage trends, and regulatory environment affecting sleep apnea device adoption, pricing strategies, and market access for manufacturers and distributors.
    • Strategic Planning Support : Leverage comprehensive US market analysis to inform product development priorities, market entry strategies, partnership opportunities, and resource allocation decisions for the 2025-2030 forecast period.

    Frequently asked questions

    What is the current size of the US sleep apnea devices market?

    The US sleep apnea devices market is estimated at $2,752.8 million in 2025.

    What is the projected market size for the US by 2030?

    The US sleep apnea devices market is forecast to reach $4,708.6 million by 2030.

    What is the growth rate of the US sleep apnea devices market?

    The US market is expected to grow at a compound annual growth rate (CAGR) of 8.0% from 2025 to 2030.

    What factors are driving growth in the US sleep apnea devices market?

    Key drivers include rising obesity rates, an aging population, improved diagnostic awareness, strong reimbursement policies, and technological advancements in device offerings.

    Which device types dominate the US sleep apnea devices market?

    CPAP and BiPAP devices remain the dominant segments in the US market, though emerging alternatives are gaining traction.

    RESEARCH METHODOLOGY

    The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches and approvals, expansions, agreements, and partnerships of the leading players, the competitive landscape of the sleep apnea devices market is analyzed to evaluate market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

    The following is a breakdown of the primary respondents:

    Sleep Apnea Devices Market

    Note 1: Others include sales, marketing, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 1 million, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    SOMNOmedcis AG (Germany) Country Manager
    ResMed (US) Regional Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of sleep apnea devices in the market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • Primary and secondary research has determined the revenues generated by leading players operating in the sleep apnea devices market.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Global Sleep Apnea Devices Market Size: Bottom-up and Top-down Approach

    Sleep Apnea Devices Market

    Data Triangulation

    After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Sleep apnea is a prevalent sleep disorder that is frequently undiagnosed, yet it poses significant health risks. This condition is characterized by intermittent cessation of breathing, which can last from several seconds to minutes, or by irregular breathing patterns. The most predominant form is obstructive sleep apnea (OSA), where anatomical or physiological obstructions impede airflow during sleep. Continuous positive airway pressure (CPAP) devices are commonly used to deliver air at elevated pressure through the nasal passages, effectively counteracting upper airway obstructions and facilitating normal respiration. These interventions are crucial for mitigating the associated morbidities linked with untreated sleep apnea.

    Stakeholders

    • Senior Management
    • Sleep Laboratories, Clinics, & Hospitals
    • Home Care Settings
    • Academic & research institutes
    • Finance/Procurement Department
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global sleep apnea devices market by product, age group, gender, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall sleep apnea devices market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence

    Get the Full Sleep Apnea Devices Market Report

    Full forecast, segment splits, and company analysis for all Sleep Apnea Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status